TITLE

Review: Hospital-at-home care does not increase mortality or readmission rates in acute exacerbations of COPD: COMMENTARY

AUTHOR(S)
Jacobs, Michael B.
PUB. DATE
May 2004
SOURCE
ACP Journal Club;May/Jun2004, Vol. 140 Issue 3, p59
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Chronic obstructive pulmonary disease (COPD) is a common illness that is costly to treat, especially when hospitalization is required for acute exacerbations. Total estimated costs in 1993 in the United States were $24 billion; 60% of these costs were directly related to hospital-based care. Given the good bioavailability of oral agents used to treat this condition with antibiotics and corticosteroids and the effectiveness of other, easy-to-administer therapies, out-of-hospital treatment of acutely ill patients with COPD should be feasible.
ACCESSION #
13221821

 

Related Articles

  • Review: Methylxanthines are not effective for acute exacerbations of chronic obstructive pulmonary disease.  // ACP Journal Club;May/Jun2004, Vol. 140 Issue 3, p60 

    This article determines the effectiveness of addition of methylxanthines to standard treatments of patients with acute exacerbations of chronic obstructive pulmonary disease (COPD). Studies were selected if they were randomized controlled trials that compared methylxanthines with placebo for...

  • Using exhaled NO concentrations to adjust inhaled corticosteroid dose maintained asthma control and reduced the dose. Smith, A. D.; Cowan, J. O.; Brassett, K. P.; Taylor, R. // Evidence Based Medicine;Feb2006, Vol. 11 Issue 1, p20 

    The article reports on a study to determine whether optimizing the inhaled corticosteroid dose using the fraction of nitric oxide in exhaled air can reduce asthma exacerbations and the daily dosage compared to the use of standard criteria for patients with chronic asthma. Patients aged 12-75...

  • Commentary. Rees, P. John // Evidence Based Medicine;Feb2006, Vol. 11 Issue 1, p20 

    The article comments on a study by A. D. Smith and colleagues to determine whether optimizing the inhaled corticosteroid dose using the fraction of nitric oxide in exhaled air can reduce asthma exacerbations and the daily dosage compared to the use of standard criteria for patients with chronic...

  • Prehospital Use of Inhaled Corticosteroids and Point Prevalence of Pneumonia at the Time of Hospital Admission: Secondary Analysis of a Multicenter Cohort Study. Festic, Emir; Bansal, Vikas; Gajic, Ognjen; Lee, Augustine S. // Mayo Clinic Proceedings;Feb2014, Vol. 89 Issue 2, p154 

    Objective: To address clinical concern regarding the use of inhaled corticosteroids (ICSs) and the risk for pneumonia, particularly among patients with chronic obstructive pulmonary disease (COPD) and asthma. Patients and Methods: A multicentered prospective cohort of patients admitted to the...

  • Comparison of the Efficacy of Nebulised Budesonide with Parenteral Corticosteroids in the Treatment of Acute Exacerbations of Chronic Obstructive Pulmonary Disease. Mirici, A.; Meral, M.; Akgun, M. // Clinical Drug Investigation;2003, Vol. 23 Issue 1, p55 

    Objective: To compare the efficacy and safety of nebulised budesonide and systemic corticosteroid in the treatment of acute exacerbations of chronic obstructive pulmonary disease (COPD). Design: Randomised, double-blind, placebo-controlled, parallel-group trial. Patients and interventions: A...

  • Triple therapy benefits COPD patients.  // Australian Journal of Pharmacy;Mar2010, Vol. 91 Issue 1078, p78 

    The article reports on the study which reveals that combining an anticholinergic with an inhaled corticosteroid and a longacting beta2-agonist may provide clinical benefits in patients with chronic obstructive pulmonary disease.

  • Does Inhaled Budesonide Produce Benefits in COPD? Walling, Anne D. // American Family Physician;11/1/1999, Vol. 60 Issue 7, p2156 

    Presents an evaluation on the treatment of chronic obstructive pulmonary disease (COPD) by inhaled corticosteroids. Long-term effects of inhaled budesonide in patients with COPD; Need for differentiation between asthma and COPD in patients with pulmonary symptoms.

  • COPD combo success.  // Nature Reviews Drug Discovery;Oct2013, Vol. 12 Issue 10, p728 

    The article focuses on several drugs for the treatment of chronic obstructive pulmonary disease (COPD), which include the inhaled corticosteroids, long-acting β2-adregeneric receptor agonists (LABAs), and long-acting muscarinic receptor antagonists (LAMAs.)

  • Inhaled corticosteroid use in patients with COPD or asthma. Kirchner, Jeffrey T. // American Family Physician;5/1/1997, Vol. 55 Issue 6, p2311 

    Focuses on the chart review conducted by Jackevicius and colleagues to determine the prevalence of inhaled corticosteroid used before and during hospitalization of patients with chronic obstructive pulmonary disease (COPD) or asthma. Methodology used in the study; Most commonly prescribed...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics